Logo (WIPO, 15.09.2016)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke wurde als Bildmarke am 15.09.2016 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Natürliche Phänomene #Kreise #Wellen, Schall und Mikrowellen #Ein Kreis #Kreise mit dunklen Flächen oder Teilen von Flächen
| Markenform | Bildmarke |
| Aktenzeichen | 1344640 |
| Länder | 
|
| Basismarke |
Nr. 87166533,
09. September 2016
|
| Anmeldedatum | 15. September 2016 |
| Ablaufdatum | 15. September 2026 |
Markeninhaber
One Broadway
Cambridge MA 02142
US
Cambridge MA 02142
US
Markenvertreter
Fross Zelnick Lehrman & Zissu, P.C.,
4 Times Square, 17th Floor
US
Waren und Dienstleistungen
09
Software for mobile devices for a diabetes support program
that connects patients and caregivers to medical service
providers and facilitates the exchange of medical data and
medical advice; mobile application for medical and condition
support for the treatment of diabetes; mobile application
for medical professionals and medical patients featuring
information relating to diabetes and related diagnostic data
input from remote locations via electronic patient
monitoring devices that feed information to the mobile
application for use by medical professionals for purposes of
monitoring and diagnosing medical conditions; mobile
application intended for diabetic patients for recording
blood test results from a blood glucose monitor; software
downloadable via the internet or mobile applications for
monitoring and tracking blood glucose levels
10
Medical monitors for the detection, measurement and
monitoring of physiological substances relating to diabetes,
and parts and components thereof; blood glucose monitors;
blood glucose monitors sold as a unit with blood glucose
monitoring kits; medical equipment for monitoring diabetes,
namely, sensors for measuring blood glucose levels, patient
monitoring sensors for biotechnology applications, drug
delivery apparatus for measuring dosages and delivering
pharmaceuticals, and apparatus for drawing or sampling blood
or other bodily fluids; injectable insulin pens sold empty;
insulin pumps for medical use sold empty; blood monitoring
apparatus
38
Telecommunications; transmission of digital files;
transmission of information and images via wireless
communication networks regarding healthcare; transmission of
information for others in the field of healthcare;
transmission of information addressed to patients or
healthcare professionals via wireless communication
networks; transmission of information and images relating to
pharmaceuticals and medicine via all means of
telecommunication including the Internet and wireless
communication networks; transmission of information via
electronic communication networks and wireless communication
networks; transmission of information in the field of
diabetes; radio broadcasting service; provision of online
forums and electronic bulletin boards for the transmission
of messages among computer users in the pharmaceutical,
medical, and healthcare fields; provision of internet chat
rooms
42
Software as a services (SAAS) featuring software for mobile
devices for a diabetes support program that connects
patients and caregivers to medical service providers and
facilitates the exchange of medical data and medical advice;
software as a services (SAAS) featuring software for mobile
devices for medical professionals and medical patients for
purposes of monitoring blood glucose levels and for purposes
of facilitating the exchange of medical data and medical
advice for the treatment of diabetes; software as a services
(SAAS) featuring software for mobile devices for medical
professionals and medical patients featuring information
relating to diabetes and related diagnostic data input from
remote locations via electronic patient monitoring devices
that feed information to the mobile application for use by
medical professionals for purposes of monitoring and
diagnosing medical conditions
44
Provision of medical and condition support for the treatment
of diabetes, by way of a mobile application; provision of
medical information for doctors, patients, and caregivers in
the field of diabetes; provision of medical and
pharmaceutical information and advice in the field of
diabetes; consulting in the field of diabetes; healthcare
services provided through disease management programs in the
field of diabetes; provision of medical information in the
field of healthcare; health care services; medical
consultation; medical services provided through disease
management programs concerning healthcare; provision of
medical information via the Internet; provision of health
and pharmaceutical information
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 10. Januar 2019 | 2019/7 Gaz | US | RAW: Partial Ceasing Effect |
| 28. März 2018 | 2018/13 Gaz | MX | Ablehnung |
| 26. März 2018 | 2018/13 Gaz | CH | Ablehnung |
| 16. März 2018 | 2018/12 Gaz | KR | Ablehnung |
| 12. Januar 2018 | 2018/3 Gaz | NO | Ablehnung |
| 06. November 2017 | 2017/45 Gaz | IN | Ablehnung |
| 20. Oktober 2017 | 2017/43 Gaz | EM | Ablehnung |
| 21. September 2017 | 2017/38 Gaz | JP | Ablehnung |
| 30. August 2017 | 2017/35 Gaz | AU | Ablehnung |
| 15. September 2016 | 2017/18 Gaz | US | Eintragung |
ID: 141344640